It has been 6 decades since Conn and Louis1 reported the first case of primary aldosteronism (PA). Now, PA is diagnosed in approximately 10% of patients with hypertension and up to 20% of individuals with resistant hypertension.2,3 Unilateral causes of hyperaldosteronism are potentially surgically curable, and adrenalectomy has been shown to be both cost-effective and to have superior outcomes compared with medical therapy.4,5 Screening is likely underused and clinical outcomes are heterogeneously reported. Greater consciousness of PA and standardized criteria for clinical outcomes therefore has the potential for a substantial effect on public health.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Wachtel H, Kelz RR. Association of Outcome Definitions With Success Following Adrenalectomy for Primary Aldosteronism. JAMA Surg. 2019;154(4):e185843. doi:10.1001/jamasurg.2018.5843
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: